Atropine
Product Images NDC 13985-606

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atropine (NDC 13985-606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mwi, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atr04 0003 01

Chemical structure diagram of atropine sulfate monohydrate showing its molecular arrangement with atoms and bonds labeled, including the phenyl group and other substituents.*

FDA Label Image

Atr04 0003 02

Atropine Sulfate Ophthalmic Solution 10 mg/mL (1%) in a 5 mL container by MWI. The label details the active ingredient concentration, preservative benzalkonium chloride, storage conditions, and includes warnings. The NDC 13985-606-05 is visible along with barcodes and lot/expiration placeholders.*

FDA Label Image

Atr04 0003 03

Atropine Sulfate Ophthalmic Solution USP 1% packaging label by MWI. The label indicates a 5 mL sterile solution for topical application to the eye, with active ingredient concentration of 1%. Included are storage instructions to keep at 20-25°C, a warning to keep out of reach of children, and a list of inactive ingredients. The label shows the product NDC 13985-606-05 and features the brand name apexa.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.